Literature DB >> 19107365

Analysis of prognostic factors for surgery after neo-adjuvant therapy for stage III non-small cell lung cancer.

Xuefeng Zhou1, Jianjun Wang, Jiashun Wang, Yongcheng Pan, Jingsong Li, Wendong Wang, Feng Zhao.   

Abstract

In order to explore the possibility to predict the risk factors for postoperative complications and survival time, the clinical data of 152 patients (including 116 males and 36 females) who had undergone neo-adjuvant therapy and surgery for stage IIIA and B non-small cell lung cancer (NSCLC) were retrospectively analyzed. Demographic data, preoperative functional parameters, staging, induction regimen (chemotherapy alone or associated with radiotherapy), associated disorders, and data about operation were collected. Chi-square test and multivariate analysis fitting the unconditional logistic regression model were performed to identify predictors of postoperative complications, while Kaplan-Meier and multivariate Cox proportional hazard model were employed to identify predictors of survival time, respectively. The univariate analysis demonstrated that forced expiratory volume in 1 second predicted percent (FEV1%, P=0.040) and associated disorders (P=0.020) were the predictive factors of complications, but multivariate analysis found no independence factors (P>0.05) of it. Univariate Kaplan-Meier analysis showed that stage (P=0.050) and pneumonectomy (P=0.018) affected the survival time. However, multivariate Cox proportional hazard model analysis demonstrated that only pneumonectomy (P=0.026) was associated with a decreased survival time, but no differences between right and left pneumonectomy were found. The results suggest that the risk factor for postoperative complications is acceptable, and pneumonectomy is associated with increased mortality, which should be performed only in stage III NSCLC patients.

Entities:  

Mesh:

Year:  2008        PMID: 19107365     DOI: 10.1007/s11596-008-0614-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  21 in total

Review 1.  Persistent air-leak following pulmonary resection.

Authors:  Thomas W Rice; Ikenna C Okereke; Eugene H Blackstone
Journal:  Chest Surg Clin N Am       Date:  2002-08

2.  Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients.

Authors:  Georgios Stamatis; Dejan Djuric; Wilfried Eberhardt; Christoph Pöttken; George Zaboura; Silvia Fechner; Toshio Fujimoto
Journal:  Eur J Cardiothorac Surg       Date:  2002-08       Impact factor: 4.191

3.  Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy.

Authors:  Fabrice Barlési; Christophe Doddoli; Jean-Philippe Torre; Roger Giudicelli; Pierre Fuentes; Pascal Thomas; Philippe Astoul
Journal:  Eur J Cardiothorac Surg       Date:  2005-10       Impact factor: 4.191

4.  Sleeve lobectomy versus pneumonectomy: tumor characteristics and comparative analysis of feasibility and results.

Authors:  Patrick Bagan; Pascal Berna; Joao Carlos Das Neves Pereira; Françoise Le Pimpec Barthes; Christophe Foucault; Antoine Dujon; Marc Riquet
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

5.  Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.

Authors:  Shin-Ichi Takeda; Hajime Maeda; Tatsuya Okada; Toshihiko Yamaguchi; Masaru Nakagawa; Soichiro Yokota; Noriyoshi Sawabata; Mitsunori Ohta
Journal:  Eur J Cardiothorac Surg       Date:  2006-05-26       Impact factor: 4.191

6.  Role of preoperative chemotherapy for non-small-cell lung cancer: a meta-analysis.

Authors:  Haruhiko Nakamura; Norihito Kawasaki; Masahiko Taguchi; Kazuyuki Kabasawa
Journal:  Lung Cancer       Date:  2006-09-20       Impact factor: 5.705

7.  Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.

Authors:  T Berghmans; M Paesmans; A P Meert; C Mascaux; P Lothaire; J J Lafitte; J P Sculier
Journal:  Lung Cancer       Date:  2005-07       Impact factor: 5.705

8.  Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results.

Authors:  Alessandro Borri; Francesco Leo; Giulia Veronesi; Piergiorgio Solli; Domenico Galetta; Roberto Gasparri; Francesco Petrella; Paolo Scanagatta; Davide Radice; Lorenzo Spaggiari
Journal:  J Thorac Cardiovasc Surg       Date:  2007-10-04       Impact factor: 5.209

Review 9.  Risks of neoadjuvant chemotherapy and radiation therapy.

Authors:  Georgios Stamatis
Journal:  Thorac Surg Clin       Date:  2008-02       Impact factor: 1.750

10.  Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: a phase II study.

Authors:  Adnan Aydiner; Murat Kiyik; Saadettin Cikrikcioglu; Filiz Kosar; Atilla Gurses; Akif Turna; Aziz Yazar; Sukru Dilege; Tuncay Goksel; Alpaslan Cakan
Journal:  Lung Cancer       Date:  2007-08-01       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.